Core Viewpoint - Shengbeila has established a high-end ecological positioning in the postpartum care industry, benefiting from the global high-net-worth family's childbirth-related industry dividends as long as the company maintains its brand image and deepens community marketing [1] Summary by Sections Market Potential - The penetration rate of postpartum care centers is low, with only 6% in mainland China as of 2024, compared to 60% in South Korea and Taiwan, indicating significant room for growth [1] - The postpartum care market is segmented into high, medium, and low-end, with high-end centers targeting high-net-worth individuals and mid-range brands catering to a large middle-class population [1] Brand Positioning - Shengbeila has opened 113 stores globally, with 31 high-end locations in first-tier cities, establishing a leading high-end service image through innovative media channels [1] - The company plans to expand into markets such as Hong Kong, Singapore, Los Angeles, and New York, aiming to tap into overseas postpartum care market opportunities [1] Marketing Strategy - The company employs effective community marketing and social viral marketing, creating interactive scenarios with target customers, which enhances emotional value and matches the physiological and psychological needs of high-net-worth individuals [2] - This marketing model results in high customer referral rates and effective cost management, reducing reliance on traditional platforms [2] Operational Efficiency - Shengbeila benefits from a flexible booking and franchise model, allowing it to secure high rental discounts without the burden of vacancy rates, thus controlling rental expenses [2] - The management center model enables low-cost, low-risk market expansion, allowing the company to achieve higher gross margins than the industry average [2] Financial Projections - Revenue projections for 2025-2027 are estimated at 1.034 billion, 1.3 billion, and 1.556 billion yuan, with corresponding net profits of 372 million, 224 million, and 316 million yuan [2] - Adjusted net profits are expected to be 115 million, 254 million, and 331 million yuan, with price-to-earnings ratios of 29X, 13X, and 10X respectively [2] Valuation - The company’s reasonable market value is estimated at 5.8 billion HKD, corresponding to a stock price of 9.38 HKD, with a "buy" rating assigned [3]

Core Viewpoint - CITIC Securities initiates coverage on Saint Bella (02508) with a "Buy" rating, projecting revenues of 1.034 billion, 1.300 billion, and 1.556 billion CNY for 2025-2027, with corresponding net profits of 372 million, 224 million, and 316 million CNY, and an adjusted net profit of 115 million, 254 million, and 331 million CNY, respectively, with a target price of 9.38 HKD [1] Group 1 - Saint Bella currently operates 113 stores globally, with 31 high-end stores in first-tier cities, establishing a strong high-end service image through new media channels [1] - The company plans to expand into markets in Hong Kong, Singapore, Los Angeles, and New York, aiming to capitalize on the overseas postpartum care market [1] - The brand's marketing strategy focuses on creating interactive scenarios with target customers, reflecting emotional value throughout the service process, which leads to high customer referral rates and effective cost management [1] Group 2 - Due to an oversupply of high-end hotels from the real estate boom, Saint Bella adopts a flexible booking model, allowing for lower rental costs without the burden of vacancy rates [2] - The management center model enables low-cost, low-risk market expansion, quickly acquiring premium resources in key locations [2] - The postpartum care business is expected to achieve higher gross margins than the industry average, with significant potential for scale effects in the single-store model [2]

Group 1: Steel Industry - The steel industry is expected to benefit from self-initiated production cuts, with industry prosperity bottoming out in Q3 2024. If the anti-involution policy promotes crude steel production cuts, it could further enhance profit recovery [2][3] - The current phase of the steel sector is characterized by policy expectation trading and fundamental improvement, similar to the previous demand downturn cycle [2][3] - The adjustment in the Chinese steel industry may resemble a prolonged battle, drawing parallels with Japan's steel development history [2] Group 2: Saint Bella (2508 HK) - Saint Bella is the largest postpartum care and recovery brand group in Asia and China, with 96 maternity centers in 30 cities globally as of June 2025. The company is rated "Buy" with a target price of HKD 9.76, corresponding to a 27X PE for 2026 [3][14] - The company is expected to achieve a revenue and adjusted net profit CAGR of 28% and 94% respectively from 2025 to 2027, driven by stable same-store growth and rapid store expansion [3] - Saint Bella aims to expand its family care and women's health product lines globally, leveraging its multi-brand and platform capabilities [3] Group 3: Yum China (9987 HK) - Yum China reported Q2 2025 revenue of USD 2.787 billion, a year-on-year increase of 4%, and an operating profit of USD 304 million, exceeding expectations [5] - The company maintains a target of opening 1,600 to 1,800 new stores in 2025, with a focus on sustaining same-store sales growth in the second half of the year [5] - The operating profit margin improved to 10.9%, reflecting the resilience of the leading brand [5] Group 4: Techtronic Industries (669 HK) - Techtronic Industries achieved a revenue of USD 7.833 billion in H1 2025, a year-on-year increase of 7.1%, with a net profit of USD 628 million, up 14.2% [6] - The growth is attributed to strong sales of flagship brands Milwaukee and RYOBI, alongside a strategic reduction in non-core business investments [6] - The company is positioned as a leading global brand in power tools and outdoor products, with a favorable long-term growth outlook [6] Group 5: Dongmu Co., Ltd. (600114 CH) - Dongmu Co., Ltd. reported H1 2025 revenue of CNY 2.930 billion, a year-on-year increase of 24.51%, and a net profit of CNY 261 million, up 37.61% [7] - The strong performance is driven by robust demand in the automotive and home appliance sectors [7] - The company is recognized as a leader in the powder metallurgy industry, maintaining an "Overweight" rating [7] Group 6: Zhongchong Co., Ltd. (002891 CH) - Zhongchong Co., Ltd. achieved H1 2025 revenue of CNY 2.432 billion, a year-on-year increase of 24.32%, with a net profit of CNY 203 million, up 42.56% [10] - The company benefits from strong domestic sales growth of 39% and an 18% increase in overseas sales due to capacity expansion [10] - The target price for 2025 is set at CNY 79.52, maintaining a "Buy" rating [10]

Group 1 - The company, Kingyung Investment (01328), announced the acquisition of 315,000 shares of Saint Bella (02508) at a total cost of approximately HKD 2.309 million, excluding transaction costs, at a price of HKD 7.3286 per share [1] - Between July 28, 2025, and August 1, 2025, Redwood, a wholly-owned subsidiary of the company, purchased a total of 1.83 million shares of Saint Bella for approximately HKD 13.823 million, at an average price of HKD 7.5536 per share [1] - Following these acquisitions, the group holds a total of 1.83 million shares of Saint Bella, representing about 0.29% of the total issued shares of Saint Bella as of the announcement date [1] Group 2 - The group primarily engages in providing investment management services and strategic direct investment [1] - The company maintains a positive outlook on Saint Bella's financial performance and future prospects, viewing it as a leading postpartum care and recovery group in China that also offers home care services and products catering to women's needs [1] - The investment in Saint Bella aligns with the group's investment criteria and serves the overall interests of the company and its shareholders [1]

Group 1 - The core announcement indicates that King Yong Investment (01328) plans to further acquire shares of Saint Bella (02508) through its wholly-owned subsidiary Redwood, with a total cost of approximately HKD 2.309 million, excluding transaction costs, for 315,000 shares at an average price of HKD 7.3286 per share [1] - Between July 28, 2025, and August 1, 2025, Redwood will acquire a total of 1.83 million shares of Saint Bella for approximately HKD 13.823 million, at an average price of HKD 7.5536 per share [1] - After these acquisitions, the group will hold a total of 1.83 million shares of Saint Bella, representing about 0.29% of the total issued shares of Saint Bella as of the announcement date [1] Group 2 - The group primarily engages in providing investment management services and strategic direct investment [1] - The group maintains a positive outlook on the financial performance and future prospects of Saint Bella, which is recognized as a leading postpartum care and recovery group in China, also offering home care services and food products catering to women's needs [1] - The investment in Saint Bella aligns with the group's investment criteria and serves the overall interests of the company and its shareholders [1]

Group 1: CaoCao Inc. (曹操出行) - CaoCao Inc. officially listed on the Hong Kong Stock Exchange on June 25, 2025, with the stock code "2643" [3] - Established in 2015, CaoCao has become one of the largest ride-hailing platforms in China, covering 136 cities as of December 31, 2024, with 85 new cities added in 2024 [3] - The total Gross Transaction Value (GTV) for 2023 and 2024 was 12.2 billion yuan and 17 billion yuan, representing growth rates of 37.5% and 38.8% respectively [3] - In Q1 2024, CaoCao's GTV reached 4.8 billion yuan, a 54.9% increase year-on-year, with order volume growing by 51.8% [3][5] - The company operates a fleet of over 34,000 customized vehicles, making it the largest fleet in China according to Frost & Sullivan [4] - CaoCao launched an autonomous driving platform in February 2024 and plans to introduce L4-level Robotaxi models by the end of 2026 [4] Group 2: SAINT BELLA Inc. (圣贝拉) - SAINT BELLA Inc. listed on the Hong Kong Stock Exchange on June 26, 2025, with the stock code "2508" [7] - The company operates 96 high-end postpartum care centers under various brands, with significant growth in self-operated and managed centers from 2022 to 2024 [7] - SAINT BELLA is recognized as the largest postpartum care and recovery group in China and Asia, with a market share of approximately 1.2% in 2024 [7] Group 3: BoKang Vision Cloud (拨康视云) - BoKang Vision Cloud plans to list on the Hong Kong Stock Exchange on July 3, 2025, with an IPO market value of approximately 8.473 billion HKD [10] - The company focuses on developing ophthalmic biotechnologies, with two core products in clinical trials for treating pterygium and myopia [11] Group 4: Stand Robot (斯坦德机器人) - Stand Robot submitted its IPO application on June 23, 2025, aiming to become the first industrial embodiment intelligent robot stock [13] - The company is recognized as the fifth largest industrial mobile robot solution provider globally, with significant growth in overseas revenue [14] - From 2022 to 2024, Stand Robot's revenue grew from 96 million yuan to 251 million yuan, with a compound annual growth rate of 61.3% [14] Group 5: Megatech (镁伽科技) - Megatech submitted its IPO application on June 25, 2025, and is the largest domestic autonomous intelligent body supplier in China [17] - The company reported a revenue growth from 455 million yuan in 2022 to 930 million yuan in 2024, with a compound annual growth rate of 43.0% [18] Group 6: Yikong Intelligent Driving (易控智驾) - Yikong Intelligent Driving plans to list on the Hong Kong Stock Exchange on June 25, 2025, and is the largest provider of L4-level autonomous driving solutions in the mining sector [21] - The company achieved a revenue increase from 60 million yuan in 2022 to 986 million yuan in 2024, with a compound annual growth rate of 305.8% [22] Group 7: Weimai (微脉) - Weimai submitted its IPO application on June 27, 2025, focusing on AI-driven full-process management services in healthcare [24] - The company reported revenue growth from 512 million yuan in 2022 to 653 million yuan in 2024, with a gross margin increase from 17.2% to 19.9% [25] Group 8: Cloud Yinggu (云英谷) - Cloud Yinggu submitted its IPO application on June 26, 2025, and is the largest AMOLED display driver chip manufacturer in mainland China [28] - The company reported a revenue increase from 551 million yuan in 2022 to 891 million yuan in 2024 [30] Group 9: Chengtai Technology (承泰科技) - Chengtai Technology submitted its IPO application on June 23, 2025, and is the largest supplier of vehicle-mounted millimeter-wave radar in China [33] - The company achieved a revenue increase from 58 million yuan in 2022 to 348 million yuan in 2024, with a compound annual growth rate of 145.7% [33] Group 10: Siwei Zhili (四维智联) - Siwei Zhili submitted its IPO application on June 27, 2025, and is a leading provider of intelligent cockpit solutions in China [36] - The company reported revenue of 539 million yuan in 2022, with a slight decline in subsequent years [36] Group 11: Haima Cloud (海马云) - Haima Cloud submitted its IPO application on June 27, 2025, and is the largest GPUaaS provider for real-time cloud rendering in China [40] - The company reported revenue growth from 290 million yuan in 2022 to 520 million yuan in 2024, with a compound annual growth rate of 33.8% [41] Group 12: Jingze Biopharma (景泽生物) - Jingze Biopharma submitted its IPO application on June 27, 2025, focusing on reproductive and ophthalmic pharmaceuticals [44] - The company has raised 927 million yuan in funding and has a pre-IPO valuation of 3.09 billion yuan [45] Group 13: Immvira Bioscience (亦诺微医药) - Immvira Bioscience submitted its IPO application on June 25, 2025, focusing on oncolytic immunotherapy and engineered exosome therapy [47] - The company has a pre-IPO valuation of 485 million USD [48]

Core Viewpoint - The Hong Kong stock market continues to experience a strong initial public offering (IPO) trend, with significant investor interest and varying performance among newly listed stocks [2][6]. Group 1: IPO Performance - In 2023, 40 new stocks have been listed in the Hong Kong market [1]. - On June 26, three new stocks were listed: Chow Tai Fook, Saint Bella, and Ying Tong Holdings, with Chow Tai Fook and Saint Bella seeing increases of 25% and 33.74% respectively, while Ying Tong Holdings experienced a decline of 16.67% [2][5]. - Among the eight new stocks listed this week, four saw price increases, with the highest being Yaojie Ankang-B, which rose by 78.71% [6]. Group 2: Investor Sentiment - The ongoing profitability from IPOs has led to heightened enthusiasm among investors, with many stocks receiving hundreds of times the subscription requests during public offerings [6]. - Chow Tai Fook and Saint Bella attracted significant investor interest, with Chow Tai Fook's public offering receiving 711.11 times subscription and Saint Bella's 193 times [7][9]. Group 3: Company Profiles - Chow Tai Fook is a leading Chinese jewelry company, consistently ranked among the top five brands in the Chinese jewelry market from 2017 to 2024, with a market share of 6.2% in total merchandise transaction value [7]. - Saint Bella is recognized as the largest postpartum care and recovery group in Asia, with a network of 96 high-end postpartum centers, and is projected to have a leading market share in cities like Hangzhou and Shanghai [9]. - Ying Tong Holdings is the largest perfume group in China, with products sold in over 400 cities and more than 100 directly operated points of sale [11].

Core Viewpoint - The Hong Kong stock market continues to experience a strong demand for new listings, with significant price increases for newly listed stocks, indicating a robust appetite from both retail and institutional investors for initial public offerings (IPOs) [1][4][6]. Group 1: New Listings Performance - Three new stocks were listed on June 26, with notable price increases: Chow Tai Fook rose by 25%, and Saint Bella surged by 33.74%, while Yingtong Holdings saw a decline of 16.67% [1][4][6]. - Among the eight new stocks listed recently, four experienced price drops, while four saw gains, with the highest increase being 78.71% for Yaojie Ankang-B [4][5]. Group 2: Investor Interest and Subscription Rates - The subscription rates for the new listings were exceptionally high, with Chow Tai Fook receiving 711.11 times oversubscription in the Hong Kong public offering and 13.55 times in the international offering [7][8]. - Saint Bella also attracted significant interest, with a subscription rate of 193 times for the Hong Kong public offering and 15.59 times for the international offering [11][12]. Group 3: Company Profiles - Chow Tai Fook is a leading Chinese jewelry company, maintaining a top-five position in the Chinese jewelry market for eight consecutive years, with a market share of 6.2% in gold jewelry and 1.0% in overall jewelry sales [6][8]. - Saint Bella is recognized as the largest postpartum care and recovery group in Asia, with a network of 96 high-end postpartum care centers, and is projected to have the largest market share in cities like Hangzhou and Shanghai by 2024 [10][12]. Group 4: Financial Highlights - Chow Tai Fook's global offering consisted of 53.83 million H-shares, with a share price of HKD 24, raising approximately HKD 1.193 billion [6][8]. - Saint Bella's global offering included 109.7 million H-shares at a price of HKD 6.58, generating around HKD 630 million [10][12]. - Yingtong Holdings offered 333.4 million shares at HKD 2.88, raising about HKD 883 million, but had lower subscription rates compared to the other two companies [14][15].

Core Viewpoint - Saint Bella's listing on the Hong Kong Stock Exchange marks a significant milestone, establishing it as the first stock in the family quality care sector in Hong Kong, with a market performance that saw its stock price rise by 46.5% to HKD 9.64, resulting in a market capitalization of HKD 5.74 billion [1][2]. Company Development - The founder, Xiang Hua, reflects on the company's journey, emphasizing a commitment to long-termism and a focus on customer needs, which has allowed the company to expand its business segments and achieve independent growth [1][3][7]. - Saint Bella has adopted a full-cycle service strategy (LTV), acquired Guanghetang, and developed home service offerings, which have contributed to its growth trajectory [1][7]. Service Quality and Innovation - The company prides itself on its high-quality services, having established the industry's first SaaS system and over 1,000 standard operating procedures (SOPs) to enhance service delivery [1][10]. - Saint Bella has innovated its care model from 1.0 to 3.0, introducing 24-hour nurse care, environment iterations, and proprietary product development, thus creating a unique market position [1][11]. Future Strategy - The company aims to maintain a focus on women and families, creating a closed-loop service model while expanding globally into major cities and introducing the "Bella Doctor" maternal and infant language model to address parenting challenges [2][12][17]. - Saint Bella's strategy includes deepening its understanding of women's long-term needs and expanding its service radius through partnerships and product offerings [16][19]. Cultural Mission - The company is committed to promoting Eastern postpartum care culture globally, aiming to connect with diverse cultures and enhance the appeal of traditional Chinese care practices [14][15][17]. - Saint Bella emphasizes humility and a customer-centric approach, valuing partnerships and competition while striving to solve real problems for its clients [18][19].

Core Viewpoint - 圣贝拉有限公司 (02508.HK) was listed on the Hong Kong Stock Exchange, closing at HKD 8.80, a rise of 33.74% from its final offering price of HKD 6.580 [1][3]. Summary by Relevant Sections Share Issuance and Capital Structure - The total number of shares offered globally by 圣贝拉 was 109,733,000, with 7,710,000 shares allocated for the Hong Kong public offering and 62,023,000 shares for international offering [1][2]. - At the time of listing, the total number of issued shares was 609,733,000 [2]. Financial Details - The total proceeds from the offering amounted to HKD 722.04 million, with net proceeds of HKD 629.95 million after deducting estimated listing expenses of HKD 92.09 million [3][4]. - The company plans to allocate approximately 29% of the net proceeds to expand its postpartum care network, 37% for launching new services and products, 6% for training family care professionals, 18% for research and development activities, and 9% for working capital and other general corporate purposes [4]. Financial Performance - 圣贝拉's revenue for the years 2022, 2023, and 2024 is projected to be RMB 471.52 million, RMB 559.91 million, and RMB 798.67 million, respectively [6][7]. - The company reported losses of RMB 411.58 million in 2022, RMB 238.89 million in 2023, and an expected loss of RMB 543.28 million in 2024 [6][7]. - The net cash flow from operating activities for the same years was RMB 24.11 million, RMB 56.70 million, and RMB 49.08 million, respectively [8].